Skip to main content
Figure 2 | BMC Medicine

Figure 2

From: Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials

Figure 2

Effects of PDE5i over placebo on cardiac geometry parameters. A) LVMi main analysis; B) LVMi subgroup analysis in patients with LVH; C) EDVi main analysis. Diamond indicates the overall summary estimate for the analysis (width of the diamond represents the 95% CI); boxes, the weight of individual studies in the pooled analysis. EDVi: end-diastolic volume index; LVH: left ventricular hypertrophy; LVMi: left ventricular mass index; PDE5i: phosphodiesterase type 5 inhibitors.

Back to article page